or
forgot password

A MULTI-CENTER LONG-TERM FOLLOW-UP STUDY OF PATIENTS WITH LOW-GRADE NON-HODGKIN'S LYMPHOMA PREVIOUSLY TREATED WITH TOSITUMOMAB AND/OR IODINE I 131 TOSITUMOMAB IN STUDIES RIT-I-000, RIT-II-001, RIT-II-002, RIT-II-004, or CP-97-012


Phase 3
18 Years
N/A
Open (Enrolling)
Both
Non-Hodgkin's Lymphoma

Thank you

Trial Information

A MULTI-CENTER LONG-TERM FOLLOW-UP STUDY OF PATIENTS WITH LOW-GRADE NON-HODGKIN'S LYMPHOMA PREVIOUSLY TREATED WITH TOSITUMOMAB AND/OR IODINE I 131 TOSITUMOMAB IN STUDIES RIT-I-000, RIT-II-001, RIT-II-002, RIT-II-004, or CP-97-012


Inclusion Criteria:



- Patients must have enrolled in one of the following Corixa sponsored clinical trials:
RIT-I-000, RIT-II-001, RIT-II-002, RIT II-004 or CP-97-012 and are >2 years post
Tositumomab and/or Iodine I 131 Tositumomab administration.

- Patients must give written informed consent by signing an IRB/ethics committee
approved consent form prior to entry on this follow-up study.

Exclusion Criteria:

- Inability to meet the above referenced inclusion criteria.

Type of Study:

Observational

Study Design:

N/A

Principal Investigator

GSK Clinical Trials, MD

Investigator Role:

Study Director

Investigator Affiliation:

GlaxoSmithKline

Authority:

United States: Food and Drug Administration

Study ID:

BEX104526

NCT ID:

NCT00240591

Start Date:

December 2003

Completion Date:

June 2010

Related Keywords:

  • Non-Hodgkin's Lymphoma
  • BEXXAR
  • Iodine I 131 Tositumomab
  • Tositumomab
  • low-grade follicular lymphomas
  • Lymphoma
  • Lymphoma, Non-Hodgkin

Name

Location

GSK Clinical Trials Call Center Hoover, Alabama  35216
GSK Clinical Trials Call Center Chula Vista, California  91911
GSK Clinical Trials Call Center Norwich, Connecticut  06360
GSK Clinical Trials Call Center Washington, District of Columbia  20307-5001
GSK Clinical Trials Call Center Gainesville, Florida  32610
GSK Clinical Trials Call Center Aurora, Illinois  60506
GSK Clinical Trials Call Center Albany, New York  12208
GSK Clinical Trials Call Center Fort Worth, Texas  76104
GSK Clinical Trials Call Center Abingdon, Virginia  24211
GSK Clinical Trials Call Center Olympia, Washington  98506
GSK Clinical Trials Call Center Omaha, Nebraska  68198-7680
GSK Clinical Trials Call Center Ann Arbor, Michigan  48109